- Report
- October 2024
- 184 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- July 2024
- 100 Pages
Global
From €3565EUR$3,750USD£2,995GBP
The Cardiac Valvulotome market is a segment of the Cardiovascular Devices industry. It is composed of medical devices used to treat valvular heart diseases, such as aortic stenosis, mitral regurgitation, and tricuspid regurgitation. These devices are used to cut and remove calcified tissue from the valve leaflets, allowing for a more effective repair or replacement of the valve. The Cardiac Valvulotome market is driven by the increasing prevalence of valvular heart diseases, technological advancements in the field, and the growing demand for minimally invasive procedures.
Some of the major companies in the Cardiac Valvulotome market include Edwards Lifesciences, Medtronic, Boston Scientific, Abbott, and Terumo Corporation. Show Less Read more